DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Teril is a drug marketed by Taro and is included in two NDAs.
The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
A generic version of TERIL was approved as carbamazepine by TARO on October 3rd, 1996.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Taro||TERIL||carbamazepine||SUSPENSION;ORAL||076729-001||Sep 20, 2004||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Taro||TERIL||carbamazepine||TABLET;ORAL||076525-001||Sep 26, 2003||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|